Imunon, Inc. (0HUZ.L)

USD 0.88

(-5.44%)

Gross Profit Summary of Imunon, Inc.

  • Imunon, Inc.'s latest annual gross profit in 2023 was -720 Thousand USD , down -210.84% from previous year.
  • Imunon, Inc.'s latest quarterly gross profit in 2024 Q2 was -2.81 Million USD , down -1481.32% from previous quarter.
  • Imunon, Inc. reported a annual gross profit of -231.62 Thousand USD in annual gross profit 2022, down -14.15% from previous year.
  • Imunon, Inc. reported a annual gross profit of -202.91 Thousand USD in annual gross profit 2021, up 98.13% from previous year.
  • Imunon, Inc. reported a quarterly gross profit of -178.31 Thousand USD for 2024 Q1, down -26.86% from previous quarter.
  • Imunon, Inc. reported a quarterly gross profit of -198.29 Thousand USD for 2023 Q3, up 93.67% from previous quarter.

Annual Gross Profit Chart of Imunon, Inc. (2023 - 2012)

Historical Annual Gross Profit of Imunon, Inc. (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 -720 Thousand USD -210.84%
2022 -231.62 Thousand USD -14.15%
2021 -202.91 Thousand USD 98.13%
2020 -10.84 Million USD 13.69%
2019 -12.56 Million USD -18.93%
2018 -10.56 Million USD 16.0%
2017 -12.57 Million USD -2615.74%
2016 500 Thousand USD 0.0%
2015 500 Thousand USD 0.0%
2014 500 Thousand USD 0.0%
2013 500 Thousand USD 0.0%
2012 - USD 0.0%

Peer Gross Profit Comparison of Imunon, Inc.

Name Gross Profit Gross Profit Difference
Atara Biotherapeutics, Inc. -313 Thousand USD -130.034%
Cara Therapeutics, Inc. 14.79 Million USD 104.867%
Editas Medicine, Inc. -99.52 Million USD 99.277%
Heron Therapeutics, Inc. 10.04 Million USD 107.17%
Iovance Biotherapeutics, Inc. -9.56 Million USD 92.473%
Walgreens Boots Alliance, Inc. 26.52 Billion USD 100.003%
uniQure N.V. 2.21 Million USD 132.506%
Aclaris Therapeutics, Inc. -85.21 Million USD 99.155%
Agios Pharmaceuticals, Inc. 17.31 Million USD 104.157%
Amicus Therapeutics, Inc. 362.03 Million USD 100.199%
bluebird bio, Inc. -4.03 Million USD 82.134%
Blueprint Medicines Corporation 236.58 Million USD 100.304%
Adicet Bio, Inc. -6.09 Million USD 88.193%
Dynavax Technologies Corporation 182.11 Million USD 100.395%
IQVIA Holdings Inc. 5.23 Billion USD 100.014%
Myriad Genetics, Inc. 476.4 Million USD 100.151%
Neurocrine Biosciences, Inc. 1.84 Billion USD 100.039%
Sarepta Therapeutics, Inc. 1.09 Billion USD 100.066%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 100.137%
Verastem, Inc. -62 Thousand USD -1061.298%
Waters Corporation 1.76 Billion USD 100.041%
Vertex Pharmaceuticals Incorporated 8.6 Billion USD 100.008%
Thermo Fisher Scientific Inc. 15.22 Billion USD 100.005%
Biogen Inc. 7.3 Billion USD 100.01%
Viking Therapeutics, Inc. -292 Thousand USD -146.577%
Perrigo Company plc 1.68 Billion USD 100.043%
Esperion Therapeutics, Inc. 73.06 Million USD 100.985%
Mettler-Toledo International Inc. 2.16 Billion USD 100.033%
Abeona Therapeutics Inc. 302 Thousand USD 338.412%
Geron Corporation -123.5 Million USD 99.417%
Illumina, Inc. 2.74 Billion USD 100.026%
Homology Medicines, Inc. -7.22 Million USD 90.04%
Nektar Therapeutics 53.47 Million USD 101.346%
Unity Biotechnology, Inc. -19.69 Million USD 96.345%
Corbus Pharmaceuticals Holdings, Inc. -31.16 Million USD 97.69%
BioMarin Pharmaceutical Inc. 1.9 Billion USD 100.038%
Sangamo Therapeutics, Inc. -45.32 Million USD 98.411%
Evolus, Inc. 140.52 Million USD 100.512%
Regeneron Pharmaceuticals, Inc. 11.3 Billion USD 100.006%
FibroGen, Inc. 128.9 Million USD 100.559%
Agilent Technologies, Inc. 3.46 Billion USD 100.021%
OPKO Health, Inc. 318.12 Million USD 100.226%
Alnylam Pharmaceuticals, Inc. 1.51 Billion USD 100.047%
Exelixis, Inc. 1.75 Billion USD 100.041%
Anavex Life Sciences Corp. - USD Infinity%
Intellia Therapeutics, Inc. -398.79 Million USD 99.819%
Zoetis Inc. 5.83 Billion USD 100.012%
Axsome Therapeutics, Inc. 244.53 Million USD 100.294%
Kala Pharmaceuticals, Inc. -303 Thousand USD -137.625%
Ionis Pharmaceuticals, Inc. 778.51 Million USD 100.092%
Corcept Therapeutics Incorporated 475.89 Million USD 100.151%
Halozyme Therapeutics, Inc. 636.89 Million USD 100.113%
Insmed Incorporated 239.63 Million USD 100.3%
TG Therapeutics, Inc. 219.1 Million USD 100.329%
Incyte Corporation 3.44 Billion USD 100.021%
Emergent BioSolutions Inc. 343.9 Million USD 100.209%